跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dayzinc - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dayzinc
Approved
STANDARD
Dayzinc
La Croesus Pharma, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
defbb05451bc4660
Company
La Croesus Pharma, Inc.
Type
Standard
Approval Details
Approval Id
defbb05451bc4660
Drug Approval Philippines Name
Dayzinc
Product Name
Dayzinc
Registration Number
DRP-2632
Brand Name
Dayzinc
Generic Name
Ascorbic Acid + Zinc
Dosage Form
Capsule
Dosage Strength
500 mg (equivalent to 562.4 mg Sodium Ascorbate)/ 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
Manufacturer
La Croesus Pharma, Inc.
Trader
Wert Philippines, Inc.
Issuance Date
26 November 2021
Expiry Date
12 November 2026
Classification
Over-The-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
defbb05451bc4660
Type
Standard
Back to Philippines FDA Approvals